Ureter and Renal Pelvis Cancer Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Detection of Ureteral Stent Encrustation
Condition: Ureteral Stent-Related Symptom Intervention: Sponsor: Fifth Affiliated Hospital, Sun Yat-Sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 10, 2022 Category: Research Source Type: clinical trials
Named Patient Program for Mitomycin for Pyelocalyceal Solution
Conditions: Urothelial Cancer of Renal Pelvis; Urothelial Carcinoma of the Renal Pelvis and Ureter; Urothelial Carcinoma Ureter; Urothelial Carcinoma Ureter Recurrent; Urothelial Carcinoma; Urothelial Carcinoma Recurrent Intervention: Drug: Mitomycin for pyelocalyceal solution Sponsors: UroGen Pharma Ltd.; Tanner Pharma Group Available (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 10, 2022 Category: Research Source Type: clinical trials
Detection of Ureteral Stent Encrustation
Condition: Ureteral Stent-Related Symptom Intervention: Sponsor: Fifth Affiliated Hospital, Sun Yat-Sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 10, 2022 Category: Research Source Type: clinical trials
Named Patient Program for Mitomycin for Pyelocalyceal Solution
Conditions: Urothelial Cancer of Renal Pelvis; Urothelial Carcinoma of the Renal Pelvis and Ureter; Urothelial Carcinoma Ureter; Urothelial Carcinoma Ureter Recurrent; Urothelial Carcinoma; Urothelial Carcinoma Recurrent Intervention: Drug: Mitomycin for pyelocalyceal solution Sponsors: UroGen Pharma Ltd.; Tanner Pharma Group Available (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 10, 2022 Category: Research Source Type: clinical trials
Detection of Ureteral Stent Encrustation
Condition: Ureteral Stent-Related Symptom Intervention: Sponsor: Fifth Affiliated Hospital, Sun Yat-Sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 10, 2022 Category: Research Source Type: clinical trials
Named Patient Program for Mitomycin for Pyelocalyceal Solution
Conditions: Urothelial Cancer of Renal Pelvis; Urothelial Carcinoma of the Renal Pelvis and Ureter; Urothelial Carcinoma Ureter; Urothelial Carcinoma Ureter Recurrent; Urothelial Carcinoma; Urothelial Carcinoma Recurrent Intervention: Drug: Mitomycin for pyelocalyceal solution Sponsors: UroGen Pharma Ltd.; Tanner Pharma Group Available (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 10, 2022 Category: Research Source Type: clinical trials
Detection of Ureteral Stent Encrustation
Condition: Ureteral Stent-Related Symptom Intervention: Sponsor: Fifth Affiliated Hospital, Sun Yat-Sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 10, 2022 Category: Research Source Type: clinical trials
Named Patient Program for Mitomycin for Pyelocalyceal Solution
Conditions: Urothelial Cancer of Renal Pelvis; Urothelial Carcinoma of the Renal Pelvis and Ureter; Urothelial Carcinoma Ureter; Urothelial Carcinoma Ureter Recurrent; Urothelial Carcinoma; Urothelial Carcinoma Recurrent Intervention: Drug: Mitomycin for pyelocalyceal solution Sponsors: UroGen Pharma Ltd.; Tanner Pharma Group Available (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 10, 2022 Category: Research Source Type: clinical trials
Detection of Ureteral Stent Encrustation
Condition: Ureteral Stent-Related Symptom Intervention: Sponsor: Fifth Affiliated Hospital, Sun Yat-Sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 10, 2022 Category: Research Source Type: clinical trials
Named Patient Program for Mitomycin for Pyelocalyceal Solution
Conditions: Urothelial Cancer of Renal Pelvis; Urothelial Carcinoma of the Renal Pelvis and Ureter; Urothelial Carcinoma Ureter; Urothelial Carcinoma Ureter Recurrent; Urothelial Carcinoma; Urothelial Carcinoma Recurrent Intervention: Drug: Mitomycin for pyelocalyceal solution Sponsors: UroGen Pharma Ltd.; Tanner Pharma Group Available (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 10, 2022 Category: Research Source Type: clinical trials
Detection of Ureteral Stent Encrustation
Condition: Ureteral Stent-Related Symptom Intervention: Sponsor: Fifth Affiliated Hospital, Sun Yat-Sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 10, 2022 Category: Research Source Type: clinical trials
Named Patient Program for Mitomycin for Pyelocalyceal Solution
Conditions: Urothelial Cancer of Renal Pelvis; Urothelial Carcinoma of the Renal Pelvis and Ureter; Urothelial Carcinoma Ureter; Urothelial Carcinoma Ureter Recurrent; Urothelial Carcinoma; Urothelial Carcinoma Recurrent Intervention: Drug: Mitomycin for pyelocalyceal solution Sponsors: UroGen Pharma Ltd.; Tanner Pharma Group Available (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 10, 2022 Category: Research Source Type: clinical trials
Ureteral Patency After Uterosacral Ligaments Suspension
Conditions: Uterovaginal Prolapse; Ureteral Injury; Surgery--Complications Intervention: Diagnostic Test: Transabdominal ultrasound and cistoscopy Sponsor: University of Milano Bicocca Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2022 Category: Research Source Type: clinical trials
